This guideline describes the approach and expertise needed for the genetic evaluation of
cardiomyopathy. First published in 2009 by the Heart Failure Society of America (HFSA), the …

Athletic training is associated with a spectrum of morphologic and functional cardiac
adaptations known as 'the athlete's heart'. 1, 2 To the purpose of the present document an …

Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium
not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a …

Myocardial diseases are associated with an increased risk of potentially fatal cardiac
arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic …

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization,
reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is …

Aims To describe a method for measuring trabeculated left ventricular (LV) mass using
cardiac magnetic resonance imaging and to assess its value in the diagnosis of left …

Non-compaction of the left ventricular myocardium (LVNC) has gained increasing
recognition during the last 25 years. There is a morphological trait of the myocardial …

Background—Patients with heart failure and chronic anemia frequently demonstrate left
ventricular (LV) trabeculations, which may be compatible with the diagnosis of LV …

Substantial progress has been made recently in understanding the genetic basis of
cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM) …

Left ventricular hypertrabeculation (LVHT) or noncompaction is a myocardial abnormality of
unknown aetiology, frequently associated with monogenic disorders, particularly …